Search research articles
Contact Us
Filters
Showing results (51-60 of 196) with videos related to
Page
of 20
Sort By:
Clinical Pharmacology and Therapeutics
|
October 10, 2018
Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study
David Hahn, Chie Emoto, Joshua C Euteneuer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 20, 2024
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 20, 2018
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
Chie Emoto, Trevor N Johnson, Sibylle Neuhoff, et al.
Therapeutic Drug Monitoring
|
October 22, 2010
Longitudinal comparison of thyroxine pharmacokinetics between pregnant and nonpregnant women: a stable isotope study
Offie P Soldin, Steven J Soldin, Alexander A Vinks, et al.
Clinical Pharmacokinetics
|
July 8, 2016
Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus
Tian Yu, Elena Y Enioutina, Hermine I Brunner, et al.
Clinical and Translational Science
|
February 22, 2025
Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease
Abigail Samuels, Kei Irie, Tomoyuki Mizuno, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 21, 2017
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
Tomoyuki Mizuno, Chie Emoto, Tsuyoshi Fukuda, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
February 5, 2010
Pharmacokinetics of amantadine in children with impaired consciousness due to acquired brain injury: preliminary findings using a sparse-sampling technique
Jilda N Vargus-Adams, Mary A McMahon, Linda J Michaud, et al.
Pharmacology & Therapeutics
|
November 23, 2021
A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome
Matthijs W van Hoogdalem, Scott L Wexelblatt, Henry T Akinbi, et al.
Frontiers in Pharmacology
|
December 19, 2022
β-lactam precision dosing in critically ill children: Current state and knowledge gaps
Sonya Tang Girdwood, Kathryn Pavia, Kelli Paice, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 196) with videos related to
Sort By:
Page
of 20
Clinical Pharmacology and Therapeutics
|
October 10, 2018
Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study
David Hahn, Chie Emoto, Joshua C Euteneuer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 20, 2024
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 20, 2018
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
Chie Emoto, Trevor N Johnson, Sibylle Neuhoff, et al.
Therapeutic Drug Monitoring
|
October 22, 2010
Longitudinal comparison of thyroxine pharmacokinetics between pregnant and nonpregnant women: a stable isotope study
Offie P Soldin, Steven J Soldin, Alexander A Vinks, et al.
Clinical Pharmacokinetics
|
July 8, 2016
Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus
Tian Yu, Elena Y Enioutina, Hermine I Brunner, et al.
Clinical and Translational Science
|
February 22, 2025
Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease
Abigail Samuels, Kei Irie, Tomoyuki Mizuno, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 21, 2017
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
Tomoyuki Mizuno, Chie Emoto, Tsuyoshi Fukuda, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
February 5, 2010
Pharmacokinetics of amantadine in children with impaired consciousness due to acquired brain injury: preliminary findings using a sparse-sampling technique
Jilda N Vargus-Adams, Mary A McMahon, Linda J Michaud, et al.
Pharmacology & Therapeutics
|
November 23, 2021
A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome
Matthijs W van Hoogdalem, Scott L Wexelblatt, Henry T Akinbi, et al.
Frontiers in Pharmacology
|
December 19, 2022
β-lactam precision dosing in critically ill children: Current state and knowledge gaps
Sonya Tang Girdwood, Kathryn Pavia, Kelli Paice, et al.
Page
of 20